FABP1 and obesity disorder: The mechanisms of FABP1 access to the nucleus and PPAR activation by specific ligands have been studied in detail, and these processes may provide a means to pharmacologically modulate PPARs, which play a role in the development of obesity, cardiovascular diseases, type 2 diabetes (T2D), and atherosclerosis (142).